Related Experiment Videos
Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene
Woong Shick Ahn1, Ko-Woon Kim, Su Mi Bae
1Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
International Journal of Experimental Pathology
|January 30, 2004
Summary
This study identified key gene and protein expression changes in uterine leiomyoma, revealing significant downregulations in cell adhesion and motility pathways crucial for disease development.
Area of Science:
- Genomics and Proteomics
- Molecular Biology
- Gynecologic Oncology
Background:
- Uterine leiomyoma (fibroids) are common benign tumors with complex pathophysiology.
- Understanding the molecular mechanisms underlying leiomyoma development is crucial for identifying therapeutic targets.
Purpose of the Study:
- To investigate gene and protein expression profiles in uterine leiomyoma.
- To identify key cellular processes and pathways involved in leiomyoma pathophysiology using gene ontology analysis.
Main Methods:
- Utilized cDNA microarray and two-dimensional protein gel electrophoresis to profile transcriptome and proteome.
- Applied gene ontology analysis to systematically characterize global expression profiles at cellular process levels.
- Compared gene and protein expression in six paired leiomyoma and normal myometrium samples.
Main Results:
- Identified 21 upregulated and 50 downregulated genes, and 33 differentially expressed proteins (17 upregulated, 16 downregulated).
- Gene ontology analysis revealed downregulations in cell adhesion, cell motility, organogenesis, and response to external stimulus.
- Upregulation was primarily observed in nucleic acid-binding activity.
Conclusions:
- Downregulated functional profiling significantly impacts the discovery of pathogenic pathways in leiomyoma.
- Gene ontology analysis provides a valuable cellular process-level approach to understand complex expression profiles.
- Identified potential prognostic candidate genes relevant to leiomyoma pathogenesis at the cellular process level.